Drugs / adipose-derived stromal cells
adipose-derived stromal cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02357485 | Mar 2014 → May 2015 | osteoarthritis, knee | Fodor, Peter B, M.D. | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adipose-derived stromal cells | “used autologous adipose-derived stromal cells (ADSC), the stromal vascular fraction (SVF), to treat 8 osteoarthritic (OA) knees in 6 patients” NCT02357485 ↗ |
| Known as | ADSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02357485 ↗ |
| Known as | stromal vascular fraction (SVF) | “used autologous adipose-derived stromal cells (ADSC), the stromal vascular fraction (SVF), to treat 8 osteoarthritic (OA) knees in 6 patients” NCT02357485 ↗ |
| Modality | Cell therapy | “autologous adipose-derived stromal cells” NCT02357485 ↗ |
| Route | Other | “injected directly into the intra-articular space” NCT02357485 ↗ |